CureVac N.V (CVAC) Research & Development: 2019-2025
Historic Research & Development for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$39.5 million.
- CureVac N.V's Research & Development fell 17.91% to -$39.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $146.0 million, marking a year-over-year increase of 21.90%. This contributed to the annual value of $163.5 million for FY2024, which is 31.34% up from last year.
- Latest data reveals that CureVac N.V reported Research & Development of -$39.5 million as of Q2 2025, which was up 0.16% from -$39.5 million recorded in Q1 2025.
- In the past 5 years, CureVac N.V's Research & Development registered a high of $279.9 million during Q4 2024, and its lowest value of -$158.1 million during Q2 2021.
- In the last 3 years, CureVac N.V's Research & Development had a median value of -$31.9 million in 2024 and averaged $20.6 million.
- Its Research & Development has fluctuated over the past 5 years, first slumped by 1,870,307.40% in 2022, then spiked by 110,529,028.85% in 2023.
- Over the past 5 years, CureVac N.V's Research & Development (Quarterly) stood at $327.18 in 2021, then plummeted by 41.06% to $192.83 in 2022, then soared by 110,529,028.85% to $213.1 million in 2023, then spiked by 31.33% to $279.9 million in 2024, then declined by 17.91% to -$39.5 million in 2025.
- Its Research & Development was -$39.5 million in Q2 2025, compared to -$39.5 million in Q1 2025 and $279.9 million in Q4 2024.